Product Images Polymyxin B
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Polymyxin B NDC 63323-367 by Fresenius Kabi Usa, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Structural Formulae - pol08 0001 01
This text includes chemical structures and names of compounds. It mentions Polymyxin B with various modifications. The compounds seem to have different chemical groups indicated by letters and symbols such as CH, CO, NH. The structure includes chains of letters and symbols connected by dashes and commas. The molecular structure is likely being described with modifications noted for each compound.*
Principal Display Panel – Carton Label - pol08 0001 02
This is a description of a pharmaceutical product with the NDC code 63323-367-44. It is Polymyxin B for Injection, USP, containing 500,000 units per vial. The package includes 105 sterile vials. The product is labeled as PRX306TI PREMIERProRx.*
Principal Display Panel – Vial Label - pol08 0001 03
This text provides information on a medication called Polymyxin B for Injection, which comes in vials each containing 500,000 units. The drug is indicated for use in hospitalized patients via specific routes like intramuscular, intravenous, and/or intrathecal administration. There is a warning about potential neuro- and nephrotoxicity, emphasizing the need for physician supervision. It also includes storage instructions both before and after reconstitution. The product is manufactured in India.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
